NEURODEGENERATIVE DISEASE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Neurodegenerative Disease Market, By Indication Type (Parkinson\\\'s Disease, Alzheimer\\\'s Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)-

Published In: 28 Apr, 2026
Code: CMI1860
Page number: 172
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026):

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Indication Type
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Rise in prevalence of neurodegenerative diseases
  - Stringent regulatory guidelines
  - Increase in demand for novel therapeutics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Neurodegenerative Disease Market, By Indication Type, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Parkinson's Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Alzheimer's Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Multiple Sclerosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Huntington Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Indication Types
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Global Neurodegenerative Disease Market, By Drug Type, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- N-methyl-D-aspartate Receptor Antagonists
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Cholinesterase Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Dopamine Agonists
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Immunomodulatory Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Drug Types
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Global Neurodegenerative Disease Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East and Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Rest of World
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
Competitive Landscape
- Abbvie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amneal Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Boehringer Ingelheim International Gmbh
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- F. Hoffmann-La Roche
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co. Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 24 market data tables and 28 figures on "Global Neurodegenerative Disease Market” - forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now